Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KLINIK FOR FYSIOTERAPI SKANDERBORG AUTORISEREDE FYSIOTERAPEUTER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 N/A 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   14.9% 8.0% 3.4% 6.3% 0.0% 2.3% 21.2% 21.2%   Credit score (0-100)   15 30 52 37 0 64 5 5   Credit rating   BB BB BBB BBB N/A BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 N/A 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,396 6,006 7,206 6,462 0.0 8,561 0.0 0.0   EBITDA   148 1,481 1,457 -706 0.0 1,727 0.0 0.0   EBIT   -23.0 1,214 1,193 -750 0.0 1,673 0.0 0.0   Pre-tax profit (PTP)   -51.0 1,184.0 1,115.0 -887.0 0.0 1,784.3 0.0 0.0   Net earnings   -41.0 919.0 864.0 -705.9 0.0 1,387.3 0.0 0.0   Pre-tax profit without non-rec. items   -51.0 1,184 1,115 -887 0.0 1,784 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 N/A 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   186 104 175 132 0.0 77.4 0.0 0.0   Shareholders equity total   202 1,196 2,060 1,354 0.0 2,742 16.6 16.6   Interest-bearing liabilities   99.0 105 712 3,072 0.0 2,504 0.0 0.0   Balance sheet total (assets)   1,233 2,655 4,328 5,518 0.0 6,086 16.6 16.6   Net Debt   96.0 101 711 3,070 0.0 2,500 -16.6 -16.6     See the entire balance sheet 1000.0 Volume  2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 N/A 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,396 6,006 7,206 6,462 0.0 8,561 0.0 0.0   Gross profit growth   10.5% 150.7% 20.0% -10.3% -100.0% 0.0% -100.0% 0.0%   Employees   6 12 13 18 0 16 0 0   Employee growth %   20.0% 100.0% 8.3% 38.5% -100.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,233 2,655 4,328 5,518 0 6,086 17 17   Balance sheet change%   -14.8% 115.3% 63.0% 27.5% -100.0% 0.0% -99.7% 0.0%   Added value   148.0 1,481.0 1,457.0 -706.1 43.5 1,727.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -305 -349 -193 -87 -132 23 -77 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 -1.0 0.0 1.0 0.0 0.0   1000.0 Profitability  2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 N/A 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -1.0% 20.2% 16.6% -11.6% 0.0% 19.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -1.7% 62.4% 34.2% -13.9% 0.0% 33.7% 0.0% 0.0%   ROI %   -4.4% 151.0% 58.7% -19.0% 0.0% 39.1% 0.0% 0.0%   ROE %   -12.7% 131.5% 53.1% -41.3% 0.0% 50.6% 0.0% 0.0%   1000.0 Solidity  2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 N/A 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   16.4% 45.0% 47.6% 24.5% 0.0% 45.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   64.9% 6.8% 48.8% -434.7% 0.0% 144.7% 0.0% 0.0%   Gearing %   49.0% 8.8% 34.6% 226.8% 0.0% 91.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   56.6% 29.4% 19.6% 10.8% 0.0% 21.2% 0.0% 0.0%   1000.0 Liquidity  2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 N/A 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.7 1.5 1.7 1.3 0.0 0.6 0.0 0.0   Current Ratio   0.9 1.7 1.8 1.4 0.0 0.8 0.0 0.0   Cash and cash equivalent   3.0 4.0 1.0 1.9 0.0 3.7 0.0 0.0   1000.0 Capital use efficiency  2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 N/A 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -82.0 988.0 1,771.0 912.3 0.0 -388.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 N/A 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   25 123 112 -39 0 108 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   25 123 112 -39 0 108 0 0   EBIT / employee   -4 101 92 -42 0 105 0 0   Net earnings / employee   -7 77 66 -39 0 87 0 0